---
schema_version: "secwatch.filing_event.v1"
accession: "0001384101-23-000065"
form_type: "8-K"
ticker: "VCYT"
cik: "0001384101"
company_name: "VERACYTE, INC."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T21:22:44.692504+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Veracyte Q1 beats: revenue $82.4M (+22%), net loss shrinks 44% to $8.1M

## Summary
- Total revenue $82.4M (+22% YoY); testing revenue $72.4M (+29%); product revenue $3.9M (+31%).
- Net loss improved 44% to $8.1M; diluted EPS -$0.11 from -$0.20.
- Total test volume 28,788 (+24%); ended cash $177.9M near flat.
- Non-GAAP gross margin 68% (vs 65%); operating expenses up 14% to $61.9M.
- Enhanced Afirma test with TERT promoter testing; secured 4 new payer contracts.

## SEC filing metadata
- accession: 0001384101-23-000065
- form_type: 8-K
- ticker: VCYT
- cik: 0001384101
- company_name: VERACYTE, INC.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1384101/000138410123000065/0001384101-23-000065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1384101/000138410123000065/vcyt-20230504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001384101-23-000065
- JSON: https://secwatch.observer/filing/0001384101-23-000065.json
- Plain text: https://secwatch.observer/filing/0001384101-23-000065.txt

## Key facts
- Earnings Releases
  VERACYTE, INC. reported the first quarter ended March 31, 2023 results: revenue $82.4 million, net income $8.1 million, EPS $0.11.
  - Period: the first quarter ended March 31, 2023
  - Revenue: $82.4 million
  - Net income: $8.1 million
  - EPS: $0.11
  - Result: reported results
  source text: EX-99.1 (EX-99.1 PRESS RELEASE 05.04.2023) --- PRESS RELEASE 05.04.2023 Document Exhibit 99.1 Veracyte Announces First Quarter 2023 Financial Results Grew Total Revenue to $82.4 million, an Increase of 22% Conference Call and Webcast Today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., May 4, 2023 --- Veracyte, Inc. (Nasdaq: VCYT) today announced financial results
  evidence_url: https://www.sec.gov/Archives/edgar/data/1384101/000138410123000065/0001384101-23-000065-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.